Conmed (CNMD) Price to Earnings (2010 - 2026)

Conmed (CNMD) has reported Price to Earnings for 17 consecutive years, with 42.49 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings fell 43.54% year-over-year to 42.49; the trailing twelve-month figure through Jun 2026 stood at 17.35 (up 18.6% YoY), and the FY2025 full-year result was 26.6, up 66.54% from the prior year.
• Price to Earnings slipped to 42.49 in Q2 2026 per CNMD's latest filing, from 76.99 in the prior quarter.
• Across five years, Price to Earnings topped out at 1745.77 in Q1 2023 and bottomed at 17.34 in Q2 2022.
• Historically, Price to Earnings has averaged 231.72 across 5 years, with a median of 89.34 in 2026.
• The sharpest annual moves came in 2022 and 2023: Price to Earnings plunged 105.75% in 2022, then soared 1854.74% in 2023.
• Over 5 years, Price to Earnings stood at 101.7 in 2022, then climbed by 0.23% to 101.93 in 2023, then sank by 38.51% to 62.67 in 2024, then climbed by 19.33% to 74.79 in 2025, then tumbled by 43.18% to 42.49 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 42.49, 76.99, and 74.79 for Q2 2026, Q1 2026, and Q4 2025 respectively.